2021 BRN Discussion, page-10703

Hi petter,

I'd say that the Akida chip will be used.

Cardea does not have a SoC. They use standard computing running computer programs.

Their business model is to partner with companies who have an application for their graphene sensor Field Effect Transistors.

https://cardeabio.com/technology/
THE CIRCUITRY
Software
With Cardean machine learning, direct multi-omics data-streams of biological signals can be used to train ML/AI algorithms on how the sub-systems of biology functions. Using a cloud-based system, Innovation Partners can access and act on streams of signals anywhere in real-time.


https://cardeabio.com/partnership-program/
Innovation Partnership Program Advantages.

Cardea’s Tech+Bio Infrastructure consists of an extensive list of Tech+Bio modules with proprietary Biology-gated Transistors, or Cardean Transistors™, at its core. These transistors are used to build chipsets, such as CRISPR-Chip™, that can be integrated into thousands of potential products and applications to be used in the field, at the bedside, or at the bench. The Tech+Bio Infrastructure allows for applications such as amplification-free genotyping, disease or pathogen monitoring, food and water safety, environmental testing, chemical detection, and biowarfare defense. (Explore some of the applications here.)

As an all-electronic detection system, Cardea’s technology does not need to amplify, add labels, or rely on optics to provide indirect estimations of biology, but instead provides direct measurements of biological interactions as they happen in reality. Applications, insights and products that used to be only dreamed of have become the new possible.

Cardea’s Tech+Bio Infrastructure is not a product sold to end-users: it’s exclusively available through the Innovation Partnership Program, as each integration is unique to a partner’s product and market.